A single-centre, retrospective analysis of mortality over 80 months comparing paclitaxel-coated balloon versus standard balloon angioplasty in the treatment of dysfunctional arteriovenous access.
Alexandra M RidingAhmed Al-NowfalSivaramakrishnan RamanarayananOscar SwiftSuresh MathavakkannanPraveen JeevaratnamKate SteinerPublished in: The journal of vascular access (2021)
In this study, mortality was not associated with the use of DCBs, but was related to established factors of dialysis longevity, age and comorbidity.